NCT06113497

Brief Summary

This study is the first prospective randomized controlled trial to analyze the effects and safety of multimodal cocktail injections after cervical laminoplasty

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
23 days until next milestone

Study Start

First participant enrolled

November 25, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

11 months

First QC Date

October 23, 2023

Last Update Submit

November 12, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change from Baseline in Pain (VAS/Visual Analog Score)

    A VAS score, also known as a Visual Analog Scale score, is a common method used in healthcare and research to measure subjective or self-reported sensations or experiences, such as pain, anxiety, mood, or other subjective states. It typically consists of a horizontal or vertical line, usually 10 centimeters in length, with anchor points at either end. One end is labeled with the most negative or extreme aspect of the sensation or experience being measured, and the other end is labeled with the most positive or least extreme aspect.

    Baseline and Post operation 7 days

  • Change from Baseline in function (JOA/Japanese Orthopaedic Association Score) score

    The JOA score is often calculated based on a specific set of criteria and is used to help guide treatment decisions and monitor a patient's progress. It provides a standardized way to assess and communicate the clinical status of individuals with cervical myelopathy. The score may range from 0 (severe impairment) to 17 (normal function), with lower scores indicating greater disability.

    Baseline and Post operation 7 days

  • Change from Baseline in function (NDI/Neck Disability Index score) score

    The NDI questionnaire typically consists of ten questions or items, and individuals are asked to rate their level of disability or limitation in various aspects of daily life due to neck pain. The questions cover a range of activities, including personal care, work, sleep, and recreational activities. Each question is scored on a scale from 0 to 5, with 0 indicating no disability and 5 indicating severe disability. The individual's responses to these questions are then totaled to calculate the NDI score, usually expressed as a percentage.

    Baseline and Post operation 7 days

Study Arms (2)

Group 1

NO INTERVENTION

The group that received normal saline 40ml injection into the deep fascia and muscular layer during wound closure.

Group 2

EXPERIMENTAL

The group that received cocktail therapy injection into the deep fascia and muscular layer during wound closure.

Drug: Cocktail injection

Interventions

Morphine 5 mg, ropivacaine 150 mg, tramadol 40 mg, epinephrine 1 mg, ketorolac 60 mg, and ketamine 1 g will be mixed with normal saline to prepare a total volume of 60 ml

Also known as: Normal saline injection
Group 2

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with cervical myelopathy or radiculopathy and scheduled to undergo laminoplasty
  • Recorded preoperative upper limb pain (Visual Analog Scale \[- VAS\] ), neck pain (VAS), Japanese Orthopaedic Association (JOA) scores, and Neck Disability Index (NDI) scores.
  • Adults aged 20 years and above, but below 80 years capable of articulating their own pain or functional abnormalities
  • Cognitive function at a level that enables them to comprehend and adhere to study procedures

You may not qualify if:

  • Previous surgical treatment of the cervical spine.
  • Adolescents aged 20 years or below, pregnant individuals, or those with the potential for pregnancy.
  • Hypersensitivity reactions to mixed medications used in Cocktail therapy. (morphine 5 mg, ropiva 150 mg, tamceton 40 mg, epinephrine 1 mg, ketocin 60 mg, jetiam 1 g).
  • Patients who lack the capacity for medical consent or are unable to communicate effectively in a medical context.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Soh J, Park HS, Lee WY, Park SH, Kang KC. The effects of multimodal cocktail analgesic local injection in postoperative pain control after laminoplasty: A study protocol of a prospective randomized controlled trial. PLoS One. 2025 Jun 13;20(6):e0324791. doi: 10.1371/journal.pone.0324791. eCollection 2025.

MeSH Terms

Interventions

Saline Solution

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Kyung-Chung Kang, Associate Professor

    Kyunghee University

    STUDY CHAIR

Central Study Contacts

Kyung-Chung Kang, Associate Professor

CONTACT

Won-Young Lee, Fellow

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Spine Center, Department of Orthopaedic Surgery

Study Record Dates

First Submitted

October 23, 2023

First Posted

November 2, 2023

Study Start

November 25, 2023

Primary Completion

October 24, 2024

Study Completion

September 30, 2025

Last Updated

November 14, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share